SG Americas Securities, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,641
-27.9%
174,569
+72.7%
0.08%
+8.6%
Q2 2023$9,211
+1161.8%
101,111
+814.0%
0.07%
+775.0%
Q1 2023$730
-55.0%
11,063
-64.7%
0.01%
-60.0%
Q4 2022$1,623
-99.9%
31,382
+12.6%
0.02%
-16.7%
Q3 2022$1,903,000
-18.7%
27,862
-46.2%
0.02%
-4.0%
Q2 2022$2,340,000
+1009.0%
51,756
+1148.6%
0.02%
+1150.0%
Q1 2022$211,000
-97.5%
4,145
-97.7%
0.00%
-95.7%
Q4 2021$8,403,000
+38.5%
177,734
-3.4%
0.05%
+64.3%
Q3 2021$6,065,000
+284.6%
184,014
+637.4%
0.03%
+300.0%
Q2 2021$1,577,000
+106.4%
24,953
+40.1%
0.01%
+75.0%
Q1 2021$764,000
+386.6%
17,811
+549.8%
0.00%
+300.0%
Q4 2020$157,000
-85.1%
2,741
-92.2%
0.00%
-85.7%
Q3 2020$1,054,000
+567.1%
34,939
+623.2%
0.01%
+600.0%
Q2 2020$158,000
-48.9%
4,831
-58.1%
0.00%
-66.7%
Q1 2020$309,000
+17.0%
11,527
+33.7%
0.00%
+50.0%
Q4 2019$264,000
-83.3%
8,622
-86.9%
0.00%
-84.6%
Q3 2019$1,585,000
+1315.2%
65,809
+1042.1%
0.01%
+1200.0%
Q1 2019$112,0005,7620.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders